Press release
Tardive Dyskinesia (TD) Treatment Market Industry Analysis, Trend and Growth, 2017-2025
Tardive dyskinesia (TD) is a disorder caused by a prolonged use of antipsychotic drugs by patients suffering from schizophrenia and other neuroleptic disorders. It is characterized by involuntary and uncontrolled movements of body parts such as eyeballs, lips, and tongue. Although tardive dyskinesia commonly occurs in patients who have been treated with antipsychotic medication for long periods, it also occurs occasionally in other conditions such as fetal alcohol syndrome, developmental disabilities, and other brain disorders, even after receiving 1 dose of causative agent. However, there are new atypical antipsychotic agents, such as olanzapine and risperidone, which have lesser risk of developing tardive dyskinesia. The disorder is linked with polymorphism of dopamine receptor gene types. The commonly used antipsychotic agents that are associated with tardive dyskinesia are chlorpromazine (Thorazine), fluphenazine (Prolixin), haloperidol (Haldol), thioridazine (Mellaril), and trifluoperazine (Stelazine). The risk of developing tardive dyskinesia is higher in older patients, women, and African & African-American population receiving antipsychotic treatment. It is estimated that approximately 500,000 people in the U.S. are affected by tardive dyskinesia each year. Increasing incidences of schizophrenia, growing bipolar disorder patients, and increasing antipsychotic prescriptions are driving the tardive dyskinesia treatment market. However, side effects of drugs, lack of awareness about the disorder and its medication, and undiagnosed cases are restricting the market growth.Request Sample Copy of the Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28307
The global tardive dyskinesia treatment market can be segmented based on type of disorder, drug class, and region. Based on the type of disorder, the market can be segmented as bradykinesias and hyperkinesias. Bradykinesias involves slowing of motion and difficulty in starting any action whereas hyperkinesias is characterized by akathisia, chorea, dystonia, myoclonus, stereotypy, tic, and tremor. Based on drug class, the market is segmented as dopamine-depleting medications (e.g., tetrabenazine, reserpine, and amantadine), GABA receptor agonist medications (e.g., clonazepam, baclofen, and valproic acid), and anticholinergic medications (e.g., trihexyphenidyl). In 2017, the FDA approved valbenazine (Ingrezza) for the treatment of adults with tardive dyskinesia. Ingrezza is manufactured by Neurocrine Biosciences, Inc, which is the first approved therapy for the treatment of the disorder. In addition, a variety of medicines are used for the treatment of tardive dyskinesia such as clonidine; however, dose limiting hypotension and sedation are its restraining factors. Botox injections are tried for minor dystonia. Vitamin B6, vitamin E, and branched chain amino acids are reported to be helpful to minimize the symptoms of the disorder. Benzodiazepine (clonazepam) is an effective therapy for tardive dyskinesia, however the development of tolerance is limiting its market growth. TEVA’s Austedo was approved for the treatment of chorea associated with Huntington’s disease; however, it is also filed for the new indication, which is for the treatment of tardive dyskinesia. Austedo is likely to create competition for Neurocrine Biosciences' Ingrezza.
Geographically, the tardive dyskinesia treatment market is distributed over North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is leading the market due to high prevalence of schizophrenia, increasing health awareness, and growing research and development investment. Middle East & Africa is the second largest market after the U.S., followed by Europe. The market in Asia Pacific is expected to grow with a decent pace during the forecast period due to increasing health awareness and growing number of schizophrenic, bipolar, and other neuroleptic disorder patients.
Key players operating in this market are Neurocrine Biosciences, Teva Pharmaceutical Industries, Valeant Pharmaceuticals, Sterimax Inc, Sun Pharma Global FZE, Pharmascience Inc., Eon Labs, Inc., Novopharm Limited, Novartis, and Oceanside Pharmaceuticals.
Request TOC of the Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=28283
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tardive Dyskinesia (TD) Treatment Market Industry Analysis, Trend and Growth, 2017-2025 here
News-ID: 715256 • Views: …
More Releases from Transparency Market Research

Point-of-Care Glucose Testing Market: Technological Innovations Shaping the Futu …
The global healthcare industry is undergoing a technological revolution, and Point-of-Care (POC) glucose testing is at the forefront of this transformation. As diabetes continues to impact millions of lives worldwide, the need for efficient, accurate, and timely glucose monitoring has become critical.
Newly released data from Transparency Market Research reveals that the global POC glucose testing market was valued at USD 3.7 billion in 2021 and is expected to reach USD…

Dental Dust Collector Market: Regional Insights and Forecasts to 2031
The dental dust collector market has been witnessing significant growth as the dental industry places a greater emphasis on occupational safety and adopts advanced technology.
Dental dust collectors play a crucial role in creating a clean and safe environment in dental clinics and laboratories by capturing harmful airborne particles produced during procedures such as drilling, grinding, and polishing.
Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85310
These devices…

Vacuum Insulation Panels Market Size Will Anticipated to Reach US$ 12.6 Billion, …
The vacuum insulation panels (VIPs) market represents a vital component in the global push for energy efficiency and thermal insulation solutions. VIPs are advanced thermal insulating materials that offer superior performance compared to traditional insulation products. These panels, composed of a core material enclosed within a gas-tight envelope, are widely used across industries, including construction, refrigeration, and logistics, where high thermal resistance is critical.
It is estimated to grow at a…

Aviation Lubricants Market Outlook 2031: Expanding from US$ 991.8 Million to US$ …
The aviation lubricants market is a crucial segment within the aerospace industry, encompassing specialized oils, greases, and fluids designed to enhance the performance and reliability of aircraft systems. These lubricants are essential for ensuring operational efficiency, reducing wear and tear, and maintaining safety standards across commercial, military, and general aviation sectors.
It is estimated to grow at a CAGR of 5.4% from 2023 to 2031 and reach US$ 1.6 Bn by…
More Releases for Pharma
Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors.
Access the PDF sample of the report@…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period.
For More Info, Get Sample Report…
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide…
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry.
Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986
Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications…